Allen Yan Lun Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Allen Yan Lun Liu has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Serena Low
Clinical Research Unit, Khoo Teck Puat Hospital, Singapore
3 shared publications - Su Chi Lim
Saw Swee Hock School of Public Heath, National University of Singapore, Singapore 117549; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232
3 shared publications - Chee Fang Sum
Admiralty Med Ctr, Diabet Ctr, Singapore, Singapore
2 shared publications Chung Cheen Chai
Division of Renal Medicine, Department of Medicine Khoo Teck Puat Hospital Singapore Singapore
2 shared publicationsEng Kuang Lim
Khoo Teck Puat Hosp, Dept Gen Med, Singapore, Singapore
2 shared publicationsMilind Nikam
Fresenius Medical Care, Singapore
2 shared publications
Latest Publications
- Open Access
- 24 December 2022
- Published by Springer Nature in BMC Nephrology
- Vol. 23 (1) , 1-13
Automated lung ultrasound image assessment using artificial intelligence to identify fluid overload in dialysis patients
Background: Fluid assessment is challenging, and fluid overload poses a significant problem among dialysis patients, with pulmonary oedema being the most serious consequence. Our study aims to develop a simple objective fluid assessment strategy using lung ultrasound (LUS) and artificial intelligence (AI) to assess the fluid status of dialysis patients. Methods: This was a single-centre study of 76 hemodialysis and peritoneal dialysis patients carried out between July 2020 to May 2022. The fluid status of dialysis patients was assessed via a simplified 8-point LUS method using a portable handheld ultrasound device (HHUSD), clinical examination and bioimpedance analysis (BIA). The primary outcome was the performance of 8-point LUS using a portable HHUSD in diagnosing fluid overload compared to physical examination and BIA. The secondary outcome was to develop and validate a novel AI software program to quantify B-line count and assess the fluid status of dialysis patients. Results: Our study showed a moderate correlation between LUS B-line count and fluid overload assessed by clinical examination (r = 0.475, p < 0.001) and BIA (r = 0.356. p < 0.001). The use of AI to detect B-lines on LUS in our study for dialysis patients was shown to have good agreement with LUS B lines observed by physicians; (r = 0.825, p < 0.001) for the training dataset and (r = 0.844, p < 0.001) for the validation dataset. Conclusion: Our study confirms that 8-point LUS using HHUSD, with AI-based detection of B lines, can provide clinically useful information on the assessment of hydration status and diagnosis of fluid overload for dialysis patients in a user-friendly and time-efficient way.
- 24 December 2022
- Published by Springer Nature in BMC Nephrology
- Vol. 23 (1) , 1-13
Open AccessAutomated lung ultrasound image assessment using artificial intelligence to identify fluid overload in dialysis patients
Background: Fluid assessment is challenging, and fluid overload poses a significant problem among dialysis patients, with pulmonary oedema being the most serious consequence. Our study aims to develop a simple objective fluid assessment strategy using lung ultrasound (LUS) and artificial intelligence (AI) to assess the fluid status of dialysis patients. Methods: This was a single-centre study of 76 hemodialysis and peritoneal dialysis patients carried out between July 2020 to May 2022. The fluid status of dialysis patients was assessed via a simplified 8-point LUS method using a portable handheld ultrasound device (HHUSD), clinical examination and bioimpedance analysis (BIA). The primary outcome was the performance of 8-point LUS using a portable HHUSD in diagnosing fluid overload compared to physical examination and BIA. The secondary outcome was to develop and validate a novel AI software program to quantify B-line count and assess the fluid status of dialysis patients. Results: Our study showed a moderate correlation between LUS B-line count and fluid overload assessed by clinical examination (r = 0.475, p < 0.001) and BIA (r = 0.356. p < 0.001). The use of AI to detect B-lines on LUS in our study for dialysis patients was shown to have good agreement with LUS B lines observed by physicians; (r = 0.825, p < 0.001) for the training dataset and (r = 0.844, p < 0.001) for the validation dataset. Conclusion: Our study confirms that 8-point LUS using HHUSD, with AI-based detection of B lines, can provide clinically useful information on the assessment of hydration status and diagnosis of fluid overload for dialysis patients in a user-friendly and time-efficient way.
- 24 November 2022
- Published by Dustri-Verlag Dr. Karl Feistle in Clinical Nephrology
- Vol. 99 (1) , 18-23
Comparison of BACTEC versus conventional enrichment medium for peritoneal dialysate fluid culture
Background: Bacterial peritonitis remains a significant cause of mortality in patients on peritoneal dialysis (PD). Early detection of causative organisms and targeted antimicrobial treatment allow for better clinical outcomes. This study compares bacterial growth results from peritoneal dialysate in the BACTEC blood culture system vs. conventional culture. Materials and methods: We conducted a prospective study on 46 patients with 63 consecutive episodes of suspected PD peritonitis between August 2020 and August 2021. PD dialysate was simultaneously sent to the laboratory in both BACTEC and sterile bottles. BACTEC bottles were incubated in the BD BACTEC FX system for 5 days. PD effluent transported from the sterile bottles was centrifuged at 3,000 rpm for 15 minutes; the supernatant was inoculated into cooked-meat broth for enrichment. Both incubation methods were extended to 14 days if microorganisms were seen on the Gram-stained smear. Recovery of isolated micro-organisms and time to detection (TTD) were compared. Results: 26 episodes of suspected PD peritonitis based on clinical criteria were identified during the study period. The sensitivity of the BACTEC and the conventional culture methods was 50% and 42.3%, respectively (p = 0.45). Seven samples had partial concordance or discordant results. McNemar's.2-test revealed no statistical difference between either method (p = 0.45). TTD was 18.9 +/- 24.4 hours via the BACTEC method vs. 37 +/- 16.5 hours in conventional cultures (p = 0.014). Conclusion: The comparable sensitivities and similar yield in identifying pathogens could be due to the enrichment medium and prolonged incubation period. The shorter TTD for the BACTEC method could facilitate earlier confirmation of bacteriological diagnosis and subsequent treatment strategies.
- 24 November 2022
- Published by Dustri-Verlag Dr. Karl Feistle in Clinical Nephrology
- Vol. 99 (1) , 18-23
Comparison of BACTEC versus conventional enrichment medium for peritoneal dialysate fluid culture
Background: Bacterial peritonitis remains a significant cause of mortality in patients on peritoneal dialysis (PD). Early detection of causative organisms and targeted antimicrobial treatment allow for better clinical outcomes. This study compares bacterial growth results from peritoneal dialysate in the BACTEC blood culture system vs. conventional culture. Materials and methods: We conducted a prospective study on 46 patients with 63 consecutive episodes of suspected PD peritonitis between August 2020 and August 2021. PD dialysate was simultaneously sent to the laboratory in both BACTEC and sterile bottles. BACTEC bottles were incubated in the BD BACTEC FX system for 5 days. PD effluent transported from the sterile bottles was centrifuged at 3,000 rpm for 15 minutes; the supernatant was inoculated into cooked-meat broth for enrichment. Both incubation methods were extended to 14 days if microorganisms were seen on the Gram-stained smear. Recovery of isolated micro-organisms and time to detection (TTD) were compared. Results: 26 episodes of suspected PD peritonitis based on clinical criteria were identified during the study period. The sensitivity of the BACTEC and the conventional culture methods was 50% and 42.3%, respectively (p = 0.45). Seven samples had partial concordance or discordant results. McNemar's.2-test revealed no statistical difference between either method (p = 0.45). TTD was 18.9 +/- 24.4 hours via the BACTEC method vs. 37 +/- 16.5 hours in conventional cultures (p = 0.014). Conclusion: The comparable sensitivities and similar yield in identifying pathogens could be due to the enrichment medium and prolonged incubation period. The shorter TTD for the BACTEC method could facilitate earlier confirmation of bacteriological diagnosis and subsequent treatment strategies.
- 25 October 2022
- Published by Wiley in Hemodialysis International
- Vol. 27 (1) , 21-27
Handheld ultrasound‐guided cannulation of difficult hemodialysis arteriovenous access: A randomized controlled trial
Introduction: Cannulation of complex arteriovenous fistula (AVF) or graft (AVG) frequently poses challenges to renal nursing practice. Ultrasound (US) guidance on visualizing central and peripheral venous access has been widely adopted in nephrology, reducing vascular intervention complications. Renal nurses could acquire this point‐of‐care technique to increase the successful cannulation rate while facilitating confidence build‐up during practice. We aim to evaluate the use of handheld US on difficult AVF/AVG cannulation in a hospital‐based dialysis unit.Methods: We conducted a single‐center randomized controlled trial from January 2021 to January 2022. Ten renal nurses were trained by an interventional nephrologist before patient recruitment and had completed a pre‐ and posttraining questionnaire on their confidence level. Fifty hemodialysis patients with complex AVF were randomized to US‐guided or conventional cannulation. The total time spent on cannulation and patients' pain scores were also collected.Findings: Renal nurses increased their confidence level after training (pretraining score 26.6 ± 6.9 vs. posttraining score 36.4 ± 3.0; p = 0.014). There was a higher success rate (only one cannulation attempt required) for US‐guided (96%) versus conventional (72.0%) cannulation (p = 0.049). US‐guided cannulation had a lower pain score than the conventional method (1.48 ± 0.73 vs. 2.13 ± 0.95, p = 0.012). The pre‐cannulation assessment time and time spent on cannulation were comparable between the two groups.Discussion: Our study showed that US‐guided cannulation increased renal nurses' confidence level in difficult cannulation and improved success rate. Larger scale studies are required to further assess the applications of handheld US in AVF cannulation, particularly in different clinical settings (e.g., chronic dialysis centers).
- 25 October 2022
- Published by Wiley in Hemodialysis International
- Vol. 27 (1) , 21-27
Handheld ultrasound‐guided cannulation of difficult hemodialysis arteriovenous access: A randomized controlled trial
Introduction: Cannulation of complex arteriovenous fistula (AVF) or graft (AVG) frequently poses challenges to renal nursing practice. Ultrasound (US) guidance on visualizing central and peripheral venous access has been widely adopted in nephrology, reducing vascular intervention complications. Renal nurses could acquire this point‐of‐care technique to increase the successful cannulation rate while facilitating confidence build‐up during practice. We aim to evaluate the use of handheld US on difficult AVF/AVG cannulation in a hospital‐based dialysis unit.Methods: We conducted a single‐center randomized controlled trial from January 2021 to January 2022. Ten renal nurses were trained by an interventional nephrologist before patient recruitment and had completed a pre‐ and posttraining questionnaire on their confidence level. Fifty hemodialysis patients with complex AVF were randomized to US‐guided or conventional cannulation. The total time spent on cannulation and patients' pain scores were also collected.Findings: Renal nurses increased their confidence level after training (pretraining score 26.6 ± 6.9 vs. posttraining score 36.4 ± 3.0; p = 0.014). There was a higher success rate (only one cannulation attempt required) for US‐guided (96%) versus conventional (72.0%) cannulation (p = 0.049). US‐guided cannulation had a lower pain score than the conventional method (1.48 ± 0.73 vs. 2.13 ± 0.95, p = 0.012). The pre‐cannulation assessment time and time spent on cannulation were comparable between the two groups.Discussion: Our study showed that US‐guided cannulation increased renal nurses' confidence level in difficult cannulation and improved success rate. Larger scale studies are required to further assess the applications of handheld US in AVF cannulation, particularly in different clinical settings (e.g., chronic dialysis centers).
- Open Access
- 16 February 2022
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 15 (7) , 1403-1414
A real-world study on SGLT2 inhibitors and diabetic kidney disease progression
Randomized controlled trials have demonstrated the benefits of sodium–glucose cotransporter 2 inhibitors (SGLT2is) in people with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). However, real-world data on CKD progression and the development of end-stage kidney disease (ESKD) remains scarce. Our aim was to study renal outcomes of people with diabetic kidney disease (DKD) using SGLT2is in a highly prevalent DKD population. Between 2016 and 2019 we recruited T2DM patients in the renal and diabetic clinics in a regional hospital in Singapore. Patients prescribed SGLT2is were compared with those on standard anti-diabetic and renoprotective treatment. The outcome measures were CKD progression [a ≥25% decrease from baseline and worsening of estimated glomerular filtration rate (eGFR) categories according to the Kidney Disease: Improving Global Outcomes guidelines] and ESKD (eGFR 2). We analysed a total of 4446 subjects; 1598 were on SGLT2is. There was a significant reduction in CKD progression {hazard ratio [HR] 0.60 [95% confidence interval (CI) 0.49–0.74]} with SGLT2is. The HR for eGFR ≥45 mL/min/1.73 m2 and 15–44 mL/min/1.73 m2 was 0.60 (95% CI 0.47–0.76) and 0.43 (95% CI 0.23–0.66), respectively. There was also a reduction in risk for developing ESKD for the entire cohort [HR 0.33 (95% CI 0.17–0.65)] and eGFR 15–44 mL/min/1.73 m2 [HR 0.24 (95% CI 0.09–0.66)]. Compared with canagliflozin and dapagliflozin, empagliflozin showed a sustained risk reduction of renal outcomes across CKD stages 1–4. This real-world study demonstrates the benefits of SGLT2is on CKD progression and ESKD. The effect is more pronounced in moderate to advanced CKD patients.
- 16 February 2022
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 15 (7) , 1403-1414
Open AccessA real-world study on SGLT2 inhibitors and diabetic kidney disease progression
Randomized controlled trials have demonstrated the benefits of sodium–glucose cotransporter 2 inhibitors (SGLT2is) in people with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). However, real-world data on CKD progression and the development of end-stage kidney disease (ESKD) remains scarce. Our aim was to study renal outcomes of people with diabetic kidney disease (DKD) using SGLT2is in a highly prevalent DKD population. Between 2016 and 2019 we recruited T2DM patients in the renal and diabetic clinics in a regional hospital in Singapore. Patients prescribed SGLT2is were compared with those on standard anti-diabetic and renoprotective treatment. The outcome measures were CKD progression [a ≥25% decrease from baseline and worsening of estimated glomerular filtration rate (eGFR) categories according to the Kidney Disease: Improving Global Outcomes guidelines] and ESKD (eGFR 2). We analysed a total of 4446 subjects; 1598 were on SGLT2is. There was a significant reduction in CKD progression {hazard ratio [HR] 0.60 [95% confidence interval (CI) 0.49–0.74]} with SGLT2is. The HR for eGFR ≥45 mL/min/1.73 m2 and 15–44 mL/min/1.73 m2 was 0.60 (95% CI 0.47–0.76) and 0.43 (95% CI 0.23–0.66), respectively. There was also a reduction in risk for developing ESKD for the entire cohort [HR 0.33 (95% CI 0.17–0.65)] and eGFR 15–44 mL/min/1.73 m2 [HR 0.24 (95% CI 0.09–0.66)]. Compared with canagliflozin and dapagliflozin, empagliflozin showed a sustained risk reduction of renal outcomes across CKD stages 1–4. This real-world study demonstrates the benefits of SGLT2is on CKD progression and ESKD. The effect is more pronounced in moderate to advanced CKD patients.
- 29 December 2021
- Published by Academy of Medicine, Singapore in Annals of the Academy of Medicine, Singapore
- Vol. 50 (12) , 919-921
Nephrologists-led intervention increases utilisation of peritoneal dialysis in Singapore
Echo pmpro_shortcode_login(''); if ($_SESSION["mmsinvalid"] == "invalid") { //echo ""; //echo "You have entered wrong User ID or password."; //echo ""; } if (empty($_REQUEST['action']) || ($_REQUEST['action'] == 'failed') || ($_REQUEST['action'] == 'empty_username') ) { echo do_shortcode(''); }
- 29 December 2021
- Published by Academy of Medicine, Singapore in Annals of the Academy of Medicine, Singapore
- Vol. 50 (12) , 919-921
Nephrologists-led intervention increases utilisation of peritoneal dialysis in Singapore
Echo pmpro_shortcode_login(''); if ($_SESSION["mmsinvalid"] == "invalid") { //echo ""; //echo "You have entered wrong User ID or password."; //echo ""; } if (empty($_REQUEST['action']) || ($_REQUEST['action'] == 'failed') || ($_REQUEST['action'] == 'empty_username') ) { echo do_shortcode(''); }
- Open Access
- 9 January 2018
- Published by Wiley in International Journal of Nephrology
- Vol. 2018, 1-17
Low, rather than High, Body Mass Index Is a Risk Factor for Acute Kidney Injury in Multiethnic Asian Patients: A Retrospective Observational Study
Background. Acute kidney injury (AKI) is common in hospitalised patients. The relationship between body mass index (BMI) and the risk of having AKI for patients in the acute hospital setting is not known, particularly in the Asian population.Methods. This was a retrospective, single-centre, observational study conducted in Singapore, a multiethnic population. All patients aged ≥21 years and hospitalised from January to December 2013 were recruited.Results. A total of 12,555 patients were eligible for the analysis. A BMI of <18.5 kg/m2was independently associated with the development of AKI in hospitalised patients (odds ratio (OR): 1.23 [95% confidence interval [CI]: 1.04–1.44,]) but not for overweight and obesity. Subgroup analysis further revealed that underweight patients aged ≥75 and repeated hospitalisation posed a higher risk of AKI (OR: 1.25 [CI: 1.01–1.56],; OR: 1.23 [CI: 1.04–1.44],, resp.). Analyses by interactions between different age groups and BMI using continuous or categorised variables did not affect the overall probability of developing AKI.Conclusions. Underweight Asian patients are susceptible to AKI in acute hospital settings. Identification of this novel risk factor for AKI allows us to optimise patient care by prevention, early detection, and timely intervention.- 9 January 2018
- Published by Wiley in International Journal of Nephrology
- Vol. 2018, 1-17
Open AccessLow, rather than High, Body Mass Index Is a Risk Factor for Acute Kidney Injury in Multiethnic Asian Patients: A Retrospective Observational Study
Background. Acute kidney injury (AKI) is common in hospitalised patients. The relationship between body mass index (BMI) and the risk of having AKI for patients in the acute hospital setting is not known, particularly in the Asian population.Methods. This was a retrospective, single-centre, observational study conducted in Singapore, a multiethnic population. All patients aged ≥21 years and hospitalised from January to December 2013 were recruited.Results. A total of 12,555 patients were eligible for the analysis. A BMI of <18.5 kg/m2was independently associated with the development of AKI in hospitalised patients (odds ratio (OR): 1.23 [95% confidence interval [CI]: 1.04–1.44,]) but not for overweight and obesity. Subgroup analysis further revealed that underweight patients aged ≥75 and repeated hospitalisation posed a higher risk of AKI (OR: 1.25 [CI: 1.01–1.56],; OR: 1.23 [CI: 1.04–1.44],, resp.). Analyses by interactions between different age groups and BMI using continuous or categorised variables did not affect the overall probability of developing AKI.Conclusions. Underweight Asian patients are susceptible to AKI in acute hospital settings. Identification of this novel risk factor for AKI allows us to optimise patient care by prevention, early detection, and timely intervention.